Global Intracranial Pressure (ICP) Monitoring Market is valued at approximately USD 0.4 billion in 2023 and is projected to grow with a healthy growth rate of more than 5.1% over the forecast period ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

When astronauts began spending six months and more aboard the International Space Station, they started to notice changes in ...

Read NASA astronaut Jonny Kim, assisted by JAXA astronaut Takuya Onishi, performs an eye ultrasound on the International ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Brain aneurysm, arteriovenous malformation (AVM) and trigeminal neuralgia are all serious neurological disorders which can ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

Brain imaging in MSA revealed that distinct cerebellar and medullary atrophy patterns were closely linked to cardiovascular ...

Veruska De Vita, a learner free diver and open-water swimmer has written a book exploring the magic of the ocean and why its ...

The deaths of two conjoined Iranian twins following unprecedented surgery to separate them has prompted an outpouring of grief around the world. Ladan Bijani died when her blood circulation failed ...

Recent studies indicate that GLP-1 receptor agonists medications such as liraglutide, widely prescribed for the treatment of type 2 diabetes and obesity could radically cut migraine frequency, giving ...